Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
reNeu Health is a healthcare technology company specializing in neuro-optimization and brain health. The company utilizes a proprietary platform that integrates advanced diagnostics, including qEEG and blood biomarkers, with personalized treatment protocols. These protocols are designed to address a variety of neurological conditions such as Alzheimer's, Parkinson's, and ADHD. Their approach combines cutting-edge technology, such as photobiomodulation and neurofeedback, with functional medicine to improve cognitive performance. reNeu Health provides both clinical services and remote monitoring solutions for patients seeking to optimize their neurological health. The company operates internationally, with a significant presence in both the United States and the United Arab Emirates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on reNeu Health Technology Trading.